Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912039 · ClinicalTrials.gov registry record
Electromyographic Assessment of the TetraGraph in Normal Volunteers
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 45
- Enrollment target
NCT02912039: Completed study, sponsored by Mayo Clinic.
NCT02912039 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912039 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
There is an urgent need for an easy-to-use and accurate quantitative neuromuscular monitor in the clinical setting. The aim of this clinical investigation is to examine a prototype of a quantitative monitoring instrument that will meet most, if not all, of the clinical requirements.
Interventions
- DEVICE TetraGraph
- DEVICE TOF Watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02912039
The ClinicalTrials.gov registry entry for NCT02912039 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TetraGraph is the first listed.
NCT02912039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02912039 about?
NCT02912039 is a clinical study titled "Electromyographic Assessment of the TetraGraph in Normal Volunteers". There is an urgent need for an easy-to-use and accurate quantitative neuromuscular monitor in the clinical setting. The aim of this clinical investigation is to examine a prototype of a quantitative monitoring instrument that will meet most, if not all, of the clinical requirements.
What is the current status of trial NCT02912039?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2016-09. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02912039?
The interventions under investigation include: TetraGraph (DEVICE), TOF Watch (DEVICE).
Who is sponsoring clinical trial NCT02912039?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.